Tochigi, Japan

Taro Sato




Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 13(Granted Patents)


Location History:

  • Shimotsuga-gun, JP (2011)
  • Tochigi, JP (2012)

Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Taro Sato: Innovator in Antimicrobial and GSK-3 Inhibitor Research

Introduction

Taro Sato is a prominent inventor based in Tochigi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with antimicrobial properties and GSK-3 inhibitors. With a total of 2 patents, Sato's work is paving the way for advancements in treating infectious diseases.

Latest Patents

Sato's latest patents include a mutilin derivative that features a heterocyclic aromatic ring carboxylic acid structure at the 14-position. This innovative mutilin analogue exhibits potent antimicrobial action against both Gram-positive and Gram-negative bacteria, including various drug-resistant strains. The compound is expected to be a valuable agent for treating infectious diseases. Additionally, he has developed 7-cycloalkylaminoquinolones as GSK-3 inhibitors. These aminoquinolones are designed to ameliorate or treat diseases mediated by GSK-3 inhibitors, showcasing Sato's commitment to addressing critical health challenges.

Career Highlights

Taro Sato is currently associated with Kyorin Pharmaceutical Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His work has garnered attention for its potential impact on public health, particularly in the fight against antibiotic resistance and related diseases.

Collaborations

Sato collaborates with notable colleagues, including Masahiro Nomura and Kyoko Okada. Their combined expertise enhances the research and development efforts at Kyorin Pharmaceutical Co., Ltd.

Conclusion

Taro Sato's innovative contributions to antimicrobial and GSK-3 inhibitor research highlight his role as a key figure in the pharmaceutical industry. His patents reflect a dedication to improving health outcomes through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…